# Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)

> **NCT00187291** · PHASE3 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 618 (—)

## Conditions studied

- Ischemic Cardiomyopathy
- LV Dysfunction

## Interventions

- **DEVICE:** T-Wave Alternans test

## Key facts

- **NCT ID:** NCT00187291
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 618 (—)
- **Last updated:** 2023-07-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187291, "Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00187291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*